Showing results (371-380 of 3,849) with videos related to
Sort By:
Pageof 385
Cancer Cell|March 12, 2015
Seek and destroy: relating cancer drivers to therapiesEmmanuel Martinez-Ledesma, John F de Groot, Roel G W VerhaakCancer Cell|March 12, 2015
Genomic analysis of smoothened inhibitor resistance in basal cell carcinomaHayley J Sharpe, Gregoire Pau, Gerrit J Dijkgraaf, et al.Cancer Cell|March 12, 2015
Smoothened variants explain the majority of drug resistance in basal cell carcinomaScott X Atwood, Kavita Y Sarin, Ramon J Whitson, et al.Cancer Cell|March 12, 2015
A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasisBodu Liu, Lijuan Sun, Qiang Liu, et al.Cancer Cell|August 5, 2020
Clinical Challenges of Immune Checkpoint InhibitorsMaria de Miguel, Emiliano CalvoCancer Cell|May 12, 2023
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in gliomaMohanraj Ramachandran, Alessandra Vaccaro, Tiarne van de Walle, et al.Cancer Cell|April 28, 2023
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancerMary Y Wu, Scott T C Shepherd, Annika Fendler, et al.Cancer Cell|April 16, 2015
Releasing the brakes: targeting FcγRIIB on B cells to enhance antibody-dependent lymphoma immunotherapyMichaela Seeling, Falk NimmerjahnCancer Cell|April 16, 2015
Antagonistic human FcγRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivoAli Roghanian, Ingrid Teige, Linda Mårtensson, et al.Cancer Cell|April 16, 2015
Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2Eric F Zhu, Shuning A Gai, Cary F Opel, et al.Pageof 385